Chiglitazar sodium

CAS: 2390374-10-2 F: C36H28FN2NaO4 W: 594.61

Chiglitazar (Carfloglitazar) is a PPARα/γ dual agonist, with EC50s of 1.2, 0.08, 1.7 μM for PPARα, PPARγ and PPARδ

Contact QiTai

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity	Chiglitazar (Carfloglitazar) is a PPARα/γ dual agonist, with EC50s of 1.2, 0.08, 1.7 μM for PPARα, PPARγ and PPARδ, respectively.
Invitro	Chiglitazar 与 Rosiglitazone 和 Pioglitazone 对 PPARγ 以及 WY14643 对 PPARα 进行了比较剂量反应研究。Chiglitazar 显示两种亚型的显著激活。Chiglitazar 的 PPARγ 激活活性弱于 Rosiglitazone，但强于 Pioglitazone。在 PPARα 激活方面，Chiglitazar 显示出比 Rosiglitazone、Pioglitazone 或选择性 PPARα 激动剂 WY14643 更有效的活性[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> Chiglitazar sodium 相关抗体:
In Vivo	注射胰岛素后，与用载体处理的对照组相比，用 Chiglitazar 或 Rosiglitazone 处理的 MSG 大鼠的血浆葡萄糖水平在所有时间点均显著降低。用 Chiglitazar 和 Rosiglitazone 处理的动物的空腹 PI 水平低于对照。用 Chiglitazar 和 Rosiglitazone 处理的 MSG 肥胖大鼠的 ISI 显著高于对照组。此外，Chiglitazar 改善了 HOMA 指数。对于 IPGTT，在葡萄糖负荷后 30 分钟，5 和 10 mg / kg Chiglitazar 和 Rosiglitazone 处理组的葡萄糖值显著低于载体处理组。处理组 IPGTT 期间葡萄糖反应积分显著低于对照组[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only.
CAS	2390374-10-2
Formula	C36H28FN2NaO4
Molar Mass	594.61
Transport	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.

(E/Z)-Ozagrel sodium